Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $8.8000 (-2%) ($8.8000 - $8.8000) on Fri. Dec. 30, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.59% (three month average) | RSI | 44 | Latest Price | $8.8000(-2%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -0.7% a day on average for past five trading days. | Weekly Trend | EDIT declines -6.4% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(57%) IWC(52%) IWM(48%) IWO(48%) IWN(46%) | Factors Impacting EDIT price | EDIT will decline at least -2.295% in a week (0% probabilities). VIXM(-12%) XBI(-11%) XME(-9%) VXX(-9%) URA(-8%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.295% (StdDev 4.59%) | Hourly BBV | 1.3 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-3.1(-135.23%) | Resistance Level | $9.43 | 5 Day Moving Average | $8.66(1.62%) | 10 Day Moving Average | $8.99(-2.11%) | 20 Day Moving Average | $9.43(-6.68%) | To recent high | -33.5% | To recent low | 5.7% | Market Cap | $547m | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |